Garri Zmudze is the Co-Founding and Managing Partner of LongeVC. See portfolio, sector focus and contact routes.
Garri Zmudze is the Co-Founding and Managing Partner of LongeVC, a global venture capital firm he launched in 2020 to invest in biotech and longevity startups. His investment thesis targets early- and mid-stage companies focused on longevity, biotech, and pet health across global geographies. Zmudze typically invests between $100,000 and $5.0 million, with a sweet spot of approximately $1.5 million per deal. Notable portfolio companies include Insilico Medicine, Basepaws, Deep Longevity, and Longenesis, where he serves as a Board Member. He also co-founded Ani.Vc and advises longevity initiatives to make longer, healthier lives more accessible. Beyond investing, Zmudze became the Executive Coordinator of the Swiss-based Longevity Science Foundation in 2021 to fund research extending the healthy human lifespan to over 120 years. He has authored articles on Cointelegraph and serves on the advisory board for PsyMed Ventures, reflecting his public engagement in longevity science.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Switzerland.
Investors like Garri Zmudze · Full investor directory · Investor access · Company funding database